Mylan boosts EpiPen patient programs, doesn’t budge on price

Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has climbed more than 600 percent over the past decade. But the drugmaker didn’t budge on its price, which has drawn ire both in Congress and from families that have had […]